LATEST UPDATES
News & Insights
Company updates, clinical perspectives and news about advances in liver-directed therapy.
Immersive Innovation at CIRSE 2026:
Experiencing the
Future of Percutaneous Hepatic Perfusion
September 25, 2026 | Delcath Systems
Understanding Metastatic Uveal Melanoma: Why the Liver Matters
Sept 11, 2026 | Delcath Systems
Why Follow-Up Matters After a Uveal Melanoma Diagnosis
Sept 8, 2026 | Delcath Systems
What is Uveal Melanoma?
August 26, 2026 | Delcath Systems
Dallas man is Texas’ first recipient of novel therapy for eye cancer that spreads to liver
July 23, 2026 | UT Southwestern Medical Center
OHSU first in Pacific Northwest to perform revolutionary new cancer treatment procedure
April 16, 2026 | OHSU News
Watch Key Updates in Metastatic Uveal Melanoma from ESMO 2025
January, 2026 | OncLive
How Does Melphalan Treat Uveal Melanoma That Spreads to the Liver?
July 28, 2025 | City of Hope
Liver-directed Therapy Offers Effective Treatment for Rare Metastatic Uveal Melanoma
July 18, 2025 | Massachusetts General
Redefining management of uveal melanoma liver metastases: what oncologists need to know
July 17, 2025 | Hospital Healthcare Europe
No Joke: UCLA Health Team Proves It's Possible to Perform High-Acuity Anesthesia Procedures Outside the OR
December, 2024 | ASA Monitor
Novel Procedure Helps Treat Renowned Chef’s Rare Eye Cancer
August 1, 2024 | UCLA Health
FDA Approves HEPZATO Kit to Treat Metastatic Ocular Melanoma
August 15, 2023 | Moffitt Cancer Center
Stay Informed about Delcath
Follow our latest company news, clinical insights, and developments in liver-directed oncology.